NR1H3 and neoplasm: Molecular and cellular clues, such as the presence of two isoforms of the receptor, LXR-α and -β, which can be selectively expressed by tumoral and non-tumoral cell components of the tumor microenvironment, and the sensitivity of different tumor-infiltrating immune cells to LXR activation/repression, might therefore explain some contrasting results obtained by different groups.